Published in Proc Natl Acad Sci U S A on April 26, 2007
The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotechnol (2008) 5.26
Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol (2007) 2.18
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
Genome-scale reconstruction of Escherichia coli's transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization. PLoS Comput Biol (2009) 2.14
Model-driven evaluation of the production potential for growth-coupled products of Escherichia coli. Metab Eng (2009) 1.96
A genome-scale metabolic reconstruction of Pseudomonas putida KT2440: iJN746 as a cell factory. BMC Syst Biol (2008) 1.81
Quantitative assignment of reaction directionality in constraint-based models of metabolism: application to Escherichia coli. Biophys Chem (2009) 1.64
The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli. BMC Genomics (2011) 1.63
OptForce: an optimization procedure for identifying all genetic manipulations leading to targeted overproductions. PLoS Comput Biol (2010) 1.51
Constraint-based model of Shewanella oneidensis MR-1 metabolism: a tool for data analysis and hypothesis generation. PLoS Comput Biol (2010) 1.48
OptORF: Optimal metabolic and regulatory perturbations for metabolic engineering of microbial strains. BMC Syst Biol (2010) 1.47
A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst Biol (2010) 1.35
The evolution of metabolic networks of E. coli. BMC Syst Biol (2011) 1.32
Large-scale identification of genetic design strategies using local search. Mol Syst Biol (2009) 1.31
Metabolic engineering for production of biorenewable fuels and chemicals: contributions of synthetic biology. J Biomed Biotechnol (2010) 1.27
In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol (2010) 1.18
Accomplishments in genome-scale in silico modeling for industrial and medical biotechnology. Biotechnol J (2009) 1.06
Structure, function, and mechanism of the nickel metalloenzymes, CO dehydrogenase, and acetyl-CoA synthase. Chem Rev (2014) 1.06
L-malate production by metabolically engineered Escherichia coli. Appl Environ Microbiol (2010) 1.04
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov Today (2013) 1.03
Large-scale bi-level strain design approaches and mixed-integer programming solution techniques. PLoS One (2011) 0.99
Genome-scale modeling for metabolic engineering. J Ind Microbiol Biotechnol (2015) 0.99
Redesigning Escherichia coli metabolism for anaerobic production of isobutanol. Appl Environ Microbiol (2011) 0.98
RELATCH: relative optimality in metabolic networks explains robust metabolic and regulatory responses to perturbations. Genome Biol (2012) 0.97
L-valine production during growth of pyruvate dehydrogenase complex-deficient Corynebacterium glutamicum in the presence of ethanol or by inactivation of the transcriptional regulator SugR. Appl Environ Microbiol (2008) 0.96
Systems metabolic engineering: genome-scale models and beyond. Biotechnol J (2010) 0.96
The genome-scale metabolic network analysis of Zymomonas mobilis ZM4 explains physiological features and suggests ethanol and succinic acid production strategies. Microb Cell Fact (2010) 0.95
Towards a carbon-negative sustainable bio-based economy. Front Plant Sci (2013) 0.95
The virus as metabolic engineer. Biotechnol J (2010) 0.94
k-OptForce: integrating kinetics with flux balance analysis for strain design. PLoS Comput Biol (2014) 0.94
FMM: a web server for metabolic pathway reconstruction and comparative analysis. Nucleic Acids Res (2009) 0.94
Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proc Natl Acad Sci U S A (2010) 0.94
The interrelationship between promoter strength, gene expression, and growth rate. PLoS One (2014) 0.92
Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement. Microb Cell Fact (2013) 0.92
Genome-scale consequences of cofactor balancing in engineered pentose utilization pathways in Saccharomyces cerevisiae. PLoS One (2011) 0.91
Engineering of Corynebacterium glutamicum for high-yield L-valine production under oxygen deprivation conditions. Appl Environ Microbiol (2012) 0.91
One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of L-tryptophan in Escherichia coli. Microb Cell Fact (2012) 0.91
Increased 3-hydroxypropionic acid production from glycerol, by modification of central metabolism in Escherichia coli. Microb Cell Fact (2014) 0.90
A Method to Constrain Genome-Scale Models with 13C Labeling Data. PLoS Comput Biol (2015) 0.90
Transcriptome analysis of a phenol-producing Pseudomonas putida S12 construct: genetic and physiological basis for improved production. J Bacteriol (2007) 0.90
An analysis of a 'community-driven' reconstruction of the human metabolic network. Metabolomics (2013) 0.90
Expanding a dynamic flux balance model of yeast fermentation to genome-scale. BMC Syst Biol (2011) 0.90
Applications of genome-scale metabolic network model in metabolic engineering. J Ind Microbiol Biotechnol (2014) 0.89
In silico aided metabolic engineering of Klebsiella oxytoca and fermentation optimization for enhanced 2,3-butanediol production. J Ind Microbiol Biotechnol (2013) 0.88
Computational evaluation of cellular metabolic costs successfully predicts genes whose expression is deleterious. Proc Natl Acad Sci U S A (2013) 0.88
Metabolic engineering of microorganisms for the production of L-arginine and its derivatives. Microb Cell Fact (2014) 0.87
Multimodal dynamic response of the Buchnera aphidicola pLeu plasmid to variations in leucine demand of its host, the pea aphid Acyrthosiphon pisum. Mol Microbiol (2011) 0.86
Scientific discovery as a combinatorial optimisation problem: how best to navigate the landscape of possible experiments? Bioessays (2012) 0.86
Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenases. Proc Natl Acad Sci U S A (2012) 0.86
Systems metabolic engineering design: fatty acid production as an emerging case study. Biotechnol Bioeng (2014) 0.85
Metabolic engineering of strains: from industrial-scale to lab-scale chemical production. J Ind Microbiol Biotechnol (2014) 0.85
Comparative 13C metabolic flux analysis of pyruvate dehydrogenase complex-deficient, L-valine-producing Corynebacterium glutamicum. Appl Environ Microbiol (2011) 0.84
FastPros: screening of reaction knockout strategies for metabolic engineering. Bioinformatics (2013) 0.84
Inducible L-alanine exporter encoded by the novel gene ygaW (alaE) in Escherichia coli. Appl Environ Microbiol (2011) 0.84
Exploiting genomic knowledge in optimising molecular breeding programmes: algorithms from evolutionary computing. PLoS One (2012) 0.84
Flux variability scanning based on enforced objective flux for identifying gene amplification targets. BMC Syst Biol (2012) 0.84
Inferring ancient metabolism using ancestral core metabolic models of enterobacteria. BMC Syst Biol (2013) 0.83
Analysis of genetic variation and potential applications in genome-scale metabolic modeling. Front Bioeng Biotechnol (2015) 0.83
Production of medium chain length polyhydroxyalkanoate in metabolic flux optimized Pseudomonas putida. Microb Cell Fact (2014) 0.83
Data-driven integration of genome-scale regulatory and metabolic network models. Front Microbiol (2015) 0.83
Metabolic analyses elucidate non-trivial gene targets for amplifying dihydroartemisinic acid production in yeast. Front Microbiol (2013) 0.83
Global transcriptome analysis of hexavalent chromium stress responses in Staphylococcus aureus LZ-01. Ecotoxicology (2014) 0.83
Rational improvement of the engineered isobutanol-producing Bacillus subtilis by elementary mode analysis. Microb Cell Fact (2012) 0.82
Expanding the concepts and tools of metabolic engineering to elucidate cancer metabolism. Biotechnol Prog (2012) 0.82
Systems modeling approaches for microbial community studies: from metagenomics to inference of the community structure. Front Microbiol (2015) 0.82
Analysing overexpression of L-valine biosynthesis genes in pyruvate-dehydrogenase-deficient Corynebacterium glutamicum. J Ind Microbiol Biotechnol (2009) 0.82
Distinct Paths for Basic Amino Acid Export in Escherichia coli: YbjE (LysO) Mediates Export of L-Lysine. J Bacteriol (2015) 0.81
Development of L-tryptophan production strains by defined genetic modification in Escherichia coli. J Ind Microbiol Biotechnol (2011) 0.81
Computational approaches in metabolic engineering. J Biomed Biotechnol (2011) 0.80
Metabolic engineering of Candida glabrata for diacetyl production. PLoS One (2014) 0.79
In Silico Constraint-Based Strain Optimization Methods: the Quest for Optimal Cell Factories. Microbiol Mol Biol Rev (2015) 0.79
Fumaric acid production in Saccharomyces cerevisiae by in silico aided metabolic engineering. PLoS One (2012) 0.79
The virtue of innovation: innovation through the lenses of biological evolution. J R Soc Interface (2015) 0.79
Cofactor specificity motifs and the induced fit mechanism in class I ketol-acid reductoisomerases. Biochem J (2015) 0.78
Elucidation of intrinsic biosynthesis yields using 13C-based metabolism analysis. Microb Cell Fact (2014) 0.78
Genome-scale metabolic model of the fission yeast Schizosaccharomyces pombe and the reconciliation of in silico/in vivo mutant growth. BMC Syst Biol (2012) 0.78
System-level strategies for studying the metabolism of Mycobacterium tuberculosis. Mol Biosyst (2010) 0.78
Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid. Microb Cell Fact (2016) 0.77
YjeH Is a Novel Exporter of l-Methionine and Branched-Chain Amino Acids in Escherichia coli. Appl Environ Microbiol (2015) 0.77
Prospects of microbial cell factories developed through systems metabolic engineering. Microb Biotechnol (2016) 0.77
Evolution, ecology and the engineered organism: lessons for synthetic biology. Genome Biol (2009) 0.77
Optimization of enzyme parameters for fermentative production of biorenewable fuels and chemicals. Comput Struct Biotechnol J (2012) 0.77
Rapid prototyping of microbial cell factories via genome-scale engineering. Biotechnol Adv (2014) 0.76
A refined genome-scale reconstruction of Chlamydomonas metabolism provides a platform for systems-level analyses. Plant J (2015) 0.76
Construction of an L-serine producing Escherichia coli via metabolic engineering. J Ind Microbiol Biotechnol (2014) 0.76
Enhanced display of lipase on the Escherichia coli cell surface, based on transcriptome analysis. Appl Environ Microbiol (2009) 0.76
Strategies for the multiplex mapping of genes to traits. Microb Cell Fact (2013) 0.76
Genome-enabled determination of amino acid biosynthesis in Xanthomonas campestris pv. campestris and identification of biosynthetic pathways for alanine, glycine, and isoleucine by 13C-isotopologue profiling. Mol Genet Genomics (2011) 0.76
Direct cadaverine production from cellobiose using β-glucosidase displaying Escherichia coli. AMB Express (2013) 0.76
Efflux systems in bacteria and their metabolic engineering applications. Appl Microbiol Biotechnol (2015) 0.76
Metabolic engineering of Escherichia coli for the production of 1,3-diaminopropane, a three carbon diamine. Sci Rep (2015) 0.75
Systems Biology Approaches to Understand Natural Products Biosynthesis. Front Bioeng Biotechnol (2015) 0.75
Designing intracellular metabolism for production of target compounds by introducing a heterologous metabolic reaction based on a Synechosystis sp. 6803 genome-scale model. Microb Cell Fact (2016) 0.75
Reconstruction of Danio rerio metabolic model accounting for subcellular compartmentalisation. PLoS One (2012) 0.75
Development of a Novel Plasmid-Free Thymidine Producer by Reprogramming Nucleotide Metabolic Pathways. Appl Environ Microbiol (2015) 0.75
Elementary Flux Mode Analysis of Acetyl-CoA Pathway in Carboxydothermus hydrogenoformans Z-2901. Adv Bioinformatics (2014) 0.75
Distinct roles of β-galactosidase paralogues of the rumen bacterium Mannheimia succiniciproducens. J Bacteriol (2011) 0.75
Dynamic genome-scale metabolic modeling of the yeast Pichia pastoris. BMC Syst Biol (2017) 0.75
Characterization of the l-alanine exporter AlaE of Escherichia coli and its potential role in protecting cells from a toxic-level accumulation of l-alanine and its derivatives. Microbiologyopen (2015) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol (2003) 10.46
Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci U S A (2002) 8.41
Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol Microbiol (1992) 4.85
The leucine-responsive regulatory protein, a global regulator of metabolism in Escherichia coli. Microbiol Rev (1994) 4.37
Molecular basis of valine resistance in Escherichia coli K-12. Proc Natl Acad Sci U S A (1981) 3.55
Multivalent translational control of transcription termination at attenuator of ilvGEDA operon of Escherichia coli K-12. Proc Natl Acad Sci U S A (1980) 3.30
The ilvIH operon of Escherichia coli is positively regulated. J Bacteriol (1990) 2.71
Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. Metab Eng (2005) 2.60
Transcriptional activation at adjacent operators in the divergent-overlapping ilvY and ilvC promoters of Escherichia coli. J Mol Biol (1988) 2.41
Lrp, a global regulatory protein of Escherichia coli, binds co-operatively to multiple sites and activates transcription of ilvIH. J Mol Biol (1993) 2.17
The nucleotide sequence of the ilvBN operon of Escherichia coli: sequence homologies of the acetohydroxy acid synthase isozymes. Nucleic Acids Res (1985) 2.12
The complete nucleotide sequence of the ilvGMEDA operon of Escherichia coli K-12. Nucleic Acids Res (1987) 2.04
Systems biotechnology for strain improvement. Trends Biotechnol (2005) 1.98
Regulation of the gltBDF operon of Escherichia coli: how is a leucine-insensitive operon regulated by the leucine-responsive regulatory protein? J Bacteriol (1993) 1.78
Molecular cloning of the gene for phosphofructokinase-2 of Escherichia coli and the nature of a mutation, pfkB1, causing a high level of the enzyme. J Mol Biol (1983) 1.75
Lrp, a leucine-responsive protein, regulates branched-chain amino acid transport genes in Escherichia coli. J Bacteriol (1992) 1.74
Global gene expression profiling in Escherichia coli K12. The effects of leucine-responsive regulatory protein. J Biol Chem (2002) 1.69
Physiological implications of the specificity of acetohydroxy acid synthase isozymes of enteric bacteria. J Bacteriol (1987) 1.45
In-depth profiling of lysine-producing Corynebacterium glutamicum by combined analysis of the transcriptome, metabolome, and fluxome. J Bacteriol (2004) 1.32
Export of L-isoleucine from Corynebacterium glutamicum: a two-gene-encoded member of a new translocator family. J Bacteriol (2002) 1.22
Global expression profiling and physiological characterization of Corynebacterium glutamicum grown in the presence of L-valine. Appl Environ Microbiol (2003) 1.21
Isolation and characterization of subunits of acetohydroxy acid synthase isozyme III and reconstitution of the holoenzyme. Biochemistry (1996) 1.19
Global analyses of transcriptomes and proteomes of a parent strain and an L-threonine-overproducing mutant strain. J Bacteriol (2003) 1.18
Feedback-resistant acetohydroxy acid synthase increases valine production in Corynebacterium glutamicum. Appl Environ Microbiol (2005) 1.10
Leucine-responsive regulatory protein-DNA interactions in the leader region of the ilvGMEDA operon of Escherichia coli. J Biol Chem (1996) 1.04
In vivo footprinting analysis of Lrp binding to the ilvIH promoter region of Escherichia coli. J Bacteriol (1994) 0.97
The yeaS (leuE) gene of Escherichia coli encodes an exporter of leucine, and the Lrp protein regulates its expression. FEBS Lett (2005) 0.96
Rational design of a Corynebacterium glutamicum pantothenate production strain and its characterization by metabolic flux analysis and genome-wide transcriptional profiling. Appl Environ Microbiol (2005) 0.96
The effect of medium composition on the production of valine by Corynebacterium 9366 - EMS/184. Folia Microbiol (Praha) (1975) 0.89
Process control for enhanced L-phenylalanine production using different recombinant Escherichia coli strains. Biotechnol Bioeng (2002) 0.88
Aerobic production of alanine by Escherichia coli aceF ldhA mutants expressing the Bacillus sphaericus alaD gene. Appl Microbiol Biotechnol (2004) 0.87
Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol (2011) 3.55
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke (2006) 2.63
Thyroid nodules with initially nondiagnostic cytologic results: the role of core-needle biopsy. Radiology (2013) 2.34
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler (2011) 2.30
Systems metabolic engineering of Escherichia coli for L-threonine production. Mol Syst Biol (2007) 2.18
Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat Chem Biol (2012) 2.17
Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation. Appl Environ Microbiol (2005) 2.13
Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol (2010) 2.11
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma. Ultrasound Med Biol (2010) 2.04
Systems biotechnology for strain improvement. Trends Biotechnol (2005) 1.98
Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.96
Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs. Nat Biotechnol (2013) 1.76
The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab (2011) 1.74
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
The genome sequence of the capnophilic rumen bacterium Mannheimia succiniciproducens. Nat Biotechnol (2004) 1.64
The genome sequence of E. coli W (ATCC 9637): comparative genome analysis and an improved genome-scale reconstruction of E. coli. BMC Genomics (2011) 1.63
Microbial production of short-chain alkanes. Nature (2013) 1.61
Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol Adv (2009) 1.60
Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke (2010) 1.53
Native-sized recombinant spider silk protein produced in metabolically engineered Escherichia coli results in a strong fiber. Proc Natl Acad Sci U S A (2010) 1.51
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol (2011) 1.50
Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide (2010) 1.50
Improved outcome after atherosclerotic stroke in male smoker. J Neurol Sci (2007) 1.48
Detection of the most common corneal dystrophies caused by BIGH3 gene point mutations using a multispot gold-capped nanoparticle array chip. Anal Chem (2010) 1.41
Recent advances in reconstruction and applications of genome-scale metabolic models. Curr Opin Biotechnol (2011) 1.41
MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis. Bioinformatics (2003) 1.40
Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. Nat Mater (2011) 1.38
Comparative multi-omics systems analysis of Escherichia coli strains B and K-12. Genome Biol (2012) 1.37
Metabolic engineering of Escherichia coli for the production of polylactic acid and its copolymers. Biotechnol Bioeng (2010) 1.36
A computerized in-hospital alert system for thrombolysis in acute stroke. Stroke (2010) 1.35
Identification and characterization of a new enoyl coenzyme A hydratase involved in biosynthesis of medium-chain-length polyhydroxyalkanoates in recombinant Escherichia coli. J Bacteriol (2003) 1.35
Genome-scale reconstruction and in silico analysis of the Clostridium acetobutylicum ATCC 824 metabolic network. Appl Microbiol Biotechnol (2008) 1.34
Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol (2006) 1.31
Application of systems biology for bioprocess development. Trends Biotechnol (2008) 1.30
Complete genome sequence of the metabolically versatile plant growth-promoting endophyte Variovorax paradoxus S110. J Bacteriol (2010) 1.29
Genome-scale analysis of Mannheimia succiniciproducens metabolism. Biotechnol Bioeng (2007) 1.28
Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2009) 1.27
Organizational and mutational analysis of a complete FR-008/candicidin gene cluster encoding a structurally related polyene complex. Chem Biol (2003) 1.27
Metabolite essentiality elucidates robustness of Escherichia coli metabolism. Proc Natl Acad Sci U S A (2007) 1.26
Bio-based production of C2-C6 platform chemicals. Biotechnol Bioeng (2012) 1.25
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf) (2004) 1.24
Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol Bioeng (2003) 1.24
Enhanced butanol production obtained by reinforcing the direct butanol-forming route in Clostridium acetobutylicum. MBio (2012) 1.24
The Escherichia coli proteome: past, present, and future prospects. Microbiol Mol Biol Rev (2006) 1.23
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab (2008) 1.23
Enhancing the working memory of stroke patients using tDCS. Am J Phys Med Rehabil (2009) 1.22
Learning curves for colonoscopy: a prospective evaluation of gastroenterology fellows at a single center. Gut Liver (2010) 1.22
Metabolic engineering of Escherichia coli for the production of cadaverine: a five carbon diamine. Biotechnol Bioeng (2011) 1.21
Genome-based metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl Environ Microbiol (2006) 1.21
Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20
MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20
Ischemic stroke and cancer: stroke severely impacts cancer patients, while cancer increases the number of strokes. J Clin Neurol (2011) 1.18
In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol (2010) 1.18
Systems metabolic engineering for chemicals and materials. Trends Biotechnol (2011) 1.17
Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience. Endocr J (2013) 1.16
Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng (2008) 1.16
Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol (2013) 1.16
Patterned multiplex pathogen DNA detection by Au particle-on-wire SERS sensor. Nano Lett (2010) 1.15
Biosynthesis of polylactic acid and its copolymers using evolved propionate CoA transferase and PHA synthase. Biotechnol Bioeng (2010) 1.14
Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol (2005) 1.14
Novel gene members in the Pho regulon of Escherichia coli. FEMS Microbiol Lett (2006) 1.13
BioSilico: an integrated metabolic database system. Bioinformatics (2004) 1.12
18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab (2007) 1.11
Continuous butanol production with reduced byproducts formation from glycerol by a hyper producing mutant of Clostridium pasteurianum. Appl Microbiol Biotechnol (2011) 1.08
Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke (2010) 1.08
Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng (2009) 1.07
Applications of DNA microarray in disease diagnostics. J Microbiol Biotechnol (2009) 1.07
Towards systems metabolic engineering of microorganisms for amino acid production. Curr Opin Biotechnol (2008) 1.07
Genome-scale metabolic model of methylotrophic yeast Pichia pastoris and its use for in silico analysis of heterologous protein production. Biotechnol J (2010) 1.07
Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol (2003) 1.06
Fermentative production of branched chain amino acids: a focus on metabolic engineering. Appl Microbiol Biotechnol (2010) 1.06
Microbial production of building block chemicals and polymers. Curr Opin Biotechnol (2011) 1.06
Prediction of novel synthetic pathways for the production of desired chemicals. BMC Syst Biol (2010) 1.05
Metabolic engineering of Clostridium acetobutylicum ATCC 824 for isopropanol-butanol-ethanol fermentation. Appl Environ Microbiol (2011) 1.05
Metabolic engineering of Escherichia coli for the production of putrescine: a four carbon diamine. Biotechnol Bioeng (2009) 1.05
Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) (2008) 1.05
DNA microarray-based identification of bacterial and fungal pathogens in bloodstream infections. Mol Cell Probes (2009) 1.04
Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today (2008) 1.04
Enhanced production of insulin-like growth factor I fusion protein in Escherichia coli by coexpression of the down-regulated genes identified by transcriptome profiling. Appl Environ Microbiol (2003) 1.03
Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics (2008) 1.02
Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst (2009) 1.02
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid (2014) 1.01
Technical and oncologic safety of robotic thyroid surgery. Ann Surg Oncol (2013) 1.01
Metabolic engineering of Escherichia coli for the production of 1-propanol. Metab Eng (2012) 1.00